Sign in

CIK 0001817713 · Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822289112
Phone
(858) 751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
  1. 8-K Event Executive or director change
  2. 8-K Event Delisting notice · Shareholder vote results
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. 8-K Event Material agreement
  13. 424B5 Offering Prospectus
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. ARS Other Annual Report to Security Holders
  17. DEFA14A Proxy Proxy Materials
  18. DEF 14A Proxy Proxy Statement
  19. 8-K Event Executive or director change
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 16 of 23 · 442 filings